Navigation Links
BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
Date:8/11/2008

LOGIES CORP. AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited)

Three Months Ended Six Months Ended

June 30 June 30,

2008 2007 2008 2007

Revenues:

Net sales $4,046 $10,832 $16,799 $11,932

Royalties 2,028 - 2,028 -

Licensing fees 266,282 289,279 532,563 578,558

Consulting fees 162,000 70,000 284,185 140,000

Total Revenues 434,356 370,111 835,575 730,490

Costs and expenses:

General and

administrative 1,173,316 812,947 1,973,772 1,910,414

Research and

development 94,432 72,060 188,703 458,419

Total Cost and

Expenses 1,267,748 885,007 2,162,475 2,368,833

Operating loss from

continuing operations (833,392) (514,896) (1,326,900) (1,638,343)

Other income (expense):

Interest income 27,528 36,894 57,803 78,143

Interest expense - - (451) -

Other income 4,527 - 4,527 -

32,055 36,894 61,879 78,143

Loss from continuing

operations before

benefit (expense) for

income tax (801,337) (478,002) (1,265,021) (1,560,200)

Income tax benefit

(expense) - - - (3,600)

Net loss from continuing

operations $(801,337) $(478,002) $(1,265,021) $(1,563,800)

Basic and diluted net

los
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
4. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
5. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
6. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
7. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
8. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
9. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
10. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
11. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- Personal Genome Diagnostics Inc. (PGDx), today announced that ... in genomic analysis of defined cancer subtypes to ... Medicines.  PGDx is an innovator in conducting patient-specific ... and Blueprint Medicines is an expert in developing ... patient population. "This collaboration brings together ...
(Date:5/21/2013)... May 21, 2013 Revolutionary Science, the ... colony counter, announced today that they have expanded their ... , the IncuCount, IntelliCount, InCount and ImpressCount. These ... are especially useful in food microbiology and pharmaceutical manufacturing. ... updated look. A bright white enclosure with jet ...
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
(Date:5/21/2013)... Possible mold re-infestation in Guilemtte School sparked concern among ... eagletribune.com posted May 14, 2013, the state is going to ... My Cleaning Products offered a tip how to kill ... said in the Eagle Tribune report (5.14.13) that the fear ... a first-grade classroom was closed due to the high-level of ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
... ... been selected by Prometheus as the sample collection kit for MyCeliacID™ a saliva-based genetic ... service as it solves sample collection challenges inherent with traditional collection methods which are ... ...
... CANTON, Mass., Aug. 18 Metabasis, a San Diego-based ... R&D equipment that is no longer essential to their ongoing ... and listed the premium lab and analytical equipment on the ... , , Metabasis is a biotech firm, ...
... , , ATLANTA, Aug. 18 ... medical device and cardiovascular tissue processing company, today announced the first ... FDA clearance. The surgeries were performed on pediatric patients at ... MI by Richard G. Ohye, M.D., associate professor of surgery, ...
Cached Biology Technology:DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test 3Massive Inventory of Premium Lab & Analytical Equipment Now Available 2CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 2CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 3CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 4
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/22/2013)... May 22, 2013 Early screening for prostate cancer ... testing is for women, thanks to UC Irvine research ... Chemical Society . , After more than a decade ... to clearly identify clinically usable markers for prostate cancer ... far sooner, with greater accuracy and at dramatically lower ...
(Date:5/22/2013)... pollinating insects and wild plants have slowed in recent ... by the University of Leeds and the Naturalis Biodiversity ... reductions in the diversity of species in Britain, Belgium ... But the picture brightened markedly after 1990, with a ... hoverflies and wild plants. , Professor Bill ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... LANSING, Mich. An engineering researcher and a global ... bringing a low-cost, hand-held device to nations with limited ... Syed Hashsham, a professor of civil and environmental ... is operated using an iPod Touch or Android-based tablet ...
... that the salmon are biting less, there are less of ... researcher at the University of Oviedo (Spain). The study, ... shows a "very marked" decline in Atlantic salmon ( Salmo ... (Asturias, northern Spain), especially during the last decade, almost simultaneously ...
... Washington, DC (August 26, 2011) African Americans are four ... new study has found that a condition that occurs when ... contributes to this increased risk. The study, conducted ... appears in an upcoming issue of the Journal of ...
Cached Biology News:Hand-held unit to detect cancer in poorer countries 2The same number of fishermen, but less salmon in Spanish rivers 2
Ready-to-use solution....
ready-to-use solution...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: